New universal JRC detection method for SARS-CoV-2

The continuous evolution of SARS-CoV-2 poses challenges for current detection tools. Since the beginning of the pandemics, SARS-CoV-2 has featured distinct sets of genetic changes able to reduce diagnostics accuracy, but also eventually evade existing immunity and confer to the virus’s higher transmissibility. 

A new RT-PCR assay for the detection of current and future SARS-CoV-2 variants has been developed by the Joint Research Centre (JRC) of the European Commission in collaboration with scientists of Luxembourg and The Netherlands, achieving another milestone in the efforts to mitigate the COVID-19 pandemic with this new universal detection method.

New universal JRC detection method for SARS-CoV-2

#HealthUnion